Southern California Compounding Pharmacy, LLC – FDA 483, Aug 1, 2019
An FDA inspection of Southern California Compounding Pharmacy, LLC in San Diego, CA, revealed significant deficiencies in aseptic processing, environmental controls, and laboratory testing for both sterile and non-sterile drug products. Observations included inadequate personnel and environmental monitoring, poor gowning and aseptic practices, and deficient cleaning procedures. The firm also failed to conduct an adequate smoke study and did not test finished non-sterile drug products for microorganisms.
ID · 85bff243-2508-4203-8c80-4d2638b4e0ea
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.